These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8260354)

  • 1. Stopping rules, interim analyses and data monitoring committees.
    Ashby D; Machin D
    Br J Cancer; 1993 Dec; 68(6):1047-50. PubMed ID: 8260354
    [No Abstract]   [Full Text] [Related]  

  • 2. Data monitoring committees and interim monitoring guidelines.
    Freidlin B; Korn EL; George SL
    Control Clin Trials; 1999 Oct; 20(5):395-407. PubMed ID: 10503800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical and ethical issues in monitoring clinical trials.
    Pocock SJ
    Stat Med; 1993 Aug; 12(15-16):1459-69; discussion 1471-5. PubMed ID: 8248657
    [No Abstract]   [Full Text] [Related]  

  • 4. Reporting on data monitoring committees in neonatal randomised controlled trials is inconsistent.
    Perrem LM; Gosling S; Ravikumar I; Khashan AS; Miletin J; Ryan CA; Dempsey E
    Acta Paediatr; 2017 Jan; 106(1):30-33. PubMed ID: 27637413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.
    Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M;
    J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The agonising negative trend in monitoring of clinical trials.
    DeMets DL; Pocock SJ; Julian DG
    Lancet; 1999 Dec; 354(9194):1983-8. PubMed ID: 10622312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data monitoring committees, interim analysis and early termination in paediatric trials.
    Fernandes RM; van der Lee JH; Offringa M
    Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interim analyses].
    Kramar A; Paoletti X
    Bull Cancer; 2007 Nov; 94(11):965-74. PubMed ID: 18055314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early viewing of noninferiority trials in progress.
    Dignam JJ
    J Clin Oncol; 2005 Aug; 23(24):5461-3. PubMed ID: 16027438
    [No Abstract]   [Full Text] [Related]  

  • 10. Is informed consent always necessary for randomized, controlled trials?
    Truog RD; Robinson W; Randolph A; Morris A
    N Engl J Med; 1999 Mar; 340(10):804-7. PubMed ID: 10072420
    [No Abstract]   [Full Text] [Related]  

  • 11. [Roaming through the methodology. XIV. The premature ending of a randomized trial].
    Vandenbroucke JP
    Ned Tijdschr Geneeskd; 1999 Jun; 143(25):1305-8. PubMed ID: 10416484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim analyses and stopping rules in cancer clinical trials.
    Whitehead J
    Br J Cancer; 1993 Dec; 68(6):1179-85. PubMed ID: 8260370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
    Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL
    Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of influenza vaccine in the elderly. Scientific scrutiny and ethical responsibility.
    Patriarca PA
    JAMA; 1994 Dec; 272(21):1700-1. PubMed ID: 7966901
    [No Abstract]   [Full Text] [Related]  

  • 15. Is informed consent always necessary for randomized, controlled trials?
    Carome MA
    N Engl J Med; 1999 Aug; 341(6):448-9; author reply 450. PubMed ID: 10438260
    [No Abstract]   [Full Text] [Related]  

  • 16. Early stopping, interim analyses, and monitoring committees: what are the tradeoffs?
    Zelen M
    J Clin Oncol; 1987 Sep; 5(9):1314-5. PubMed ID: 3625252
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethics committees for "high tech" innovations in Japan.
    Kimura R
    J Med Philos; 1989 Aug; 14(4):457-64. PubMed ID: 2778417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring clinical trials. Dissemination of decisions on interim analyses needs wider debate.
    Bird SM
    BMJ; 2001 Dec; 323(7326):1424. PubMed ID: 11744570
    [No Abstract]   [Full Text] [Related]  

  • 19. Early stopping rules in oncology: considerations for clinicians.
    Mukherjee SD; Goffin JR; Taylor V; Anderson KK; Pond GR
    Eur J Cancer; 2011 Nov; 47(16):2381-6. PubMed ID: 21684153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring clinical trials--interim data should be publicly available.
    Lilford RJ; Braunholtz D; Edwards S; Stevens A
    BMJ; 2001 Aug; 323(7310):441-2. PubMed ID: 11520848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.